32 related articles for article (PubMed ID: 27038543)
1. [Effect of Sunitinib on Pyroptosis of Drug-Resistant Leukemia K562/ADR Cells and Its Pathway].
Lin YF; Huang YY; Hong XY; Wu W; Lin DH; Xue Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Auguest; 31(5):1272-1277. PubMed ID: 37846671
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of SCN5A overcomes ABC transporter-mediated multidrug resistance in acute myeloid leukemia through promoting apoptosis.
Xu K; Zhuang XX; Shi XW
Expert Rev Hematol; 2024; 17(1-3):87-94. PubMed ID: 38230679
[TBL] [Abstract][Full Text] [Related]
3. Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide.
Khodakarami A; Kashani MA; Nazer A; Kheshti AM; Rashidi B; Karpisheh V; Masjedi A; Abolhasani S; Izadi S; Bagherifar R; Hejazian SS; Mohammadi H; Movassaghpour A; Feizi AAH; Hojjat-Farsangi M; Jadidi-Niaragh F
Cell Commun Signal; 2023 Aug; 21(1):188. PubMed ID: 37528446
[TBL] [Abstract][Full Text] [Related]
4. Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets.
Qin R; You FM; Zhao Q; Xie X; Peng C; Zhan G; Han B
J Hematol Oncol; 2022 Sep; 15(1):133. PubMed ID: 36104717
[TBL] [Abstract][Full Text] [Related]
5. The molecular biology and therapeutic potential of Nrf2 in leukemia.
Khodakarami A; Adibfar S; Karpisheh V; Abolhasani S; Jalali P; Mohammadi H; Gholizadeh Navashenaq J; Hojjat-Farsangi M; Jadidi-Niaragh F
Cancer Cell Int; 2022 Jul; 22(1):241. PubMed ID: 35906617
[TBL] [Abstract][Full Text] [Related]
6. Targeting IFN-γ-inducible lysosomal thiol reductase overcomes chemoresistance in AML through regulating the ROS-mediated mitochondrial damage.
Niu LT; Wang YQ; Wong CCL; Gao SX; Mo XD; Huang XJ
Transl Oncol; 2021 Sep; 14(9):101159. PubMed ID: 34252711
[TBL] [Abstract][Full Text] [Related]
7. AITC induces MRP1 expression by protecting against CS/CSE-mediated DJ-1 protein degradation
Xu L; Wu J; Li N; Jiang C; Guo Y; Cao P; Wang D
Korean J Physiol Pharmacol; 2020 Nov; 24(6):481-492. PubMed ID: 33093270
[TBL] [Abstract][Full Text] [Related]
8. PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers.
Liu R; Chen Y; Liu G; Li C; Song Y; Cao Z; Li W; Hu J; Lu C; Liu Y
Cell Death Dis; 2020 Sep; 11(9):797. PubMed ID: 32973135
[TBL] [Abstract][Full Text] [Related]
9. Targeting NRF2, Regulator of Antioxidant System, to Sensitize Glioblastoma Neurosphere Cells to Radiation-Induced Oxidative Stress.
Godoy PRDV; Pour Khavari A; Rizzo M; Sakamoto-Hojo ET; Haghdoost S
Oxid Med Cell Longev; 2020; 2020():2534643. PubMed ID: 32617133
[TBL] [Abstract][Full Text] [Related]
10. Molecular Mechanism of Matrine from
Chen Z; Nishimura N; Okamoto T; Wada K; Naora K
Biomed Res Int; 2019; 2019():1269532. PubMed ID: 31871929
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological Effects of Verticine: Current Status.
Yin Z; Zhang J; Guo Q; Chen L; Zhang W; Kang W
Evid Based Complement Alternat Med; 2019; 2019():2394605. PubMed ID: 30956677
[TBL] [Abstract][Full Text] [Related]
12. Nrf2 induces cisplatin resistance via suppressing the iron export related gene SLC40A1 in ovarian cancer cells.
Wu J; Bao L; Zhang Z; Yi X
Oncotarget; 2017 Nov; 8(55):93502-93515. PubMed ID: 29212168
[TBL] [Abstract][Full Text] [Related]
13. The Novel Triazolonaphthalimide Derivative LSS-11 Synergizes the Anti-Proliferative Effect of Paclitaxel via STAT3-Dependent MDR1 and MRP1 Downregulation in Chemoresistant Lung Cancer Cells.
Ji L; Liu X; Zhang S; Tang S; Yang S; Li S; Qi X; Yu S; Lu L; Meng X; Liu Z
Molecules; 2017 Oct; 22(11):. PubMed ID: 29072615
[TBL] [Abstract][Full Text] [Related]
14. MCAM Mediates Chemoresistance in Small-Cell Lung Cancer via the PI3K/AKT/SOX2 Signaling Pathway.
Tripathi SC; Fahrmann JF; Celiktas M; Aguilar M; Marini KD; Jolly MK; Katayama H; Wang H; Murage EN; Dennison JB; Watkins DN; Levine H; Ostrin EJ; Taguchi A; Hanash SM
Cancer Res; 2017 Aug; 77(16):4414-4425. PubMed ID: 28646020
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative effect of ZSTK474 alone or in combination with chemotherapeutic drugs on HL60 and HL60/ADR cells.
Zhou Q; Chen Y; Zhang L; Zhong Y; Zhang Z; Wang R; Jin M; Gong M; Qiu Y; Kong D
Oncotarget; 2017 Jun; 8(24):39064-39076. PubMed ID: 28388564
[TBL] [Abstract][Full Text] [Related]
16. Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance.
Ayers D; Vandesompele J
Genes (Basel); 2017 Mar; 8(3):. PubMed ID: 28273813
[TBL] [Abstract][Full Text] [Related]
17. TP53 mutation-mediated genomic instability induces the evolution of chemoresistance and recurrence in epithelial ovarian cancer.
Zhang M; Zhuang G; Sun X; Shen Y; Wang W; Li Q; Di W
Diagn Pathol; 2017 Feb; 12(1):16. PubMed ID: 28148293
[TBL] [Abstract][Full Text] [Related]
18. Ursolic acid sensitizes cisplatin-resistant HepG2/DDP cells to cisplatin via inhibiting Nrf2/ARE pathway.
Wu S; Zhang T; Du J
Drug Des Devel Ther; 2016; 10():3471-3481. PubMed ID: 27822011
[TBL] [Abstract][Full Text] [Related]
19. Chaetominine reduces MRP1-mediated drug resistance via inhibiting PI3K/Akt/Nrf2 signaling pathway in K562/Adr human leukemia cells.
Yao J; Wei X; Lu Y
Biochem Biophys Res Commun; 2016 May; 473(4):867-873. PubMed ID: 27038543
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
